Solar for Pharmaceutical Manufacturing
The Renata PLC case study
Pharmaceutical manufacturing runs on uninterrupted, regulated power, which makes solar adoption in this sector a more careful engineering decision than in many other industries. Cynergy Limited has delivered rooftop solar EPC across two Renata PLC manufacturing sites in Bangladesh, Rajendrapur and Kashore, demonstrating that solar can integrate cleanly into a regulated pharmaceutical production environment.
Two Renata PLC Sites, Two Rooftop Solar Installations
Cynergy’s work with Renata PLC spans two separate facilities:
- Renata PLC, Rajendrapur: a 1.08 MWp rooftop solar installation.
- Renata PLC, Kashore: a 2.74 MWp rooftop solar installation.
Together, these two sites represent close to 4 MWp of rooftop solar capacity delivered to one of Bangladesh’s pharmaceutical manufacturers.
Why Regulated Manufacturing Sites Need a Different Approach
Pharmaceutical facilities operate under strict regulatory and quality-control requirements, meaning any rooftop installation has to account for structural integrity, controlled-environment considerations, and continuity of power supply to sensitive manufacturing processes. As with all Cynergy rooftop solar projects, this starts with a structural assessment of the roof and careful integration planning so the solar system supplements the facility’s grid supply without introducing operational risk to production.
A Template for Bangladesh's Pharmaceutical and Regulated Manufacturing Sector
The Renata PLC installations show that solar EPC isn’t limited to straightforward industrial buildings, it can be engineered to fit regulated, quality-sensitive manufacturing environments as well. For pharmaceutical, healthcare, or other regulated manufacturers considering solar, get in touch with Cynergy Limited to discuss a site assessment tailored to your facility’s specific operational requirements.